LUYE Pharma Group was established in 1994 in China and lists in Hong Kong Exchanges.
We focus on developing, producing, marketing and selling innovative pharmaceutical
products in three of the largest and fastest growing therapeutic areas in the PRC—oncology, cardiovascular system, and alimentary tract and metabolism. Besides, CNS is expected to become another key area of focus.